Plasma levels of high mobility group box 1 increase in patients with posttraumatic stress disorder after severe blunt chest trauma: A prospective cohort study

Journal of Surgical Research

Volumn 193, Issue 1, 2015, Pages 308-315

  Wang, Xiao Wen ^a   Karki, Avash ^b   Du, Ding Yuan ^c   Zhao, Xing Ji ^c   Xiang, Xiao Yong ^b   Lu, Zhi Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c CHONGQING EMERGENCY MEDICAL CENTER   (China)

Author keywords

Chest trauma; High mobility group box 1; Inflammation; Post traumatic stress disorder

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; BIOLOGICAL MARKER; HMGB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THORAX BLUNT TRAUMA; TRANSFUSION; TRAUMATOLOGY; ADOLESCENT; BLOOD; INFLAMMATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; THORACIC INJURIES; WOUNDS, NONPENETRATING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STRESS DISORDERS, POST-TRAUMATIC; THORACIC INJURIES; TRAUMA SEVERITY INDICES; WOUNDS, NONPENETRATING; YOUNG ADULT;

EID: 84925024455     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.06.020     Document Type: Article

References (50)

1. Soreide K. Epidemiology of major trauma. Br J Surg 2009;96: 697.
2. Mayberry JC. Imaging in thoracic trauma: the trauma surgeon's perspective. J Thorac Imaging 2000;15:76.
3. Lewis FR. Thoracic trauma. Surg Clin North Am 1982;62:97.
4. Dougall AM, Paul ME, Finely RJ, et al. Chest traumadcurrent morbidity and mortality. J Trauma 1977;17:547.
5. Shorr RM, Crittenden M, Indeck M, et al. Blunt thoracic trauma. Analysis of 515 patients. Ann Surg 1987;206:200.
6. Gaillard M, Herve C, Mandin L, et al. Mortality prognostic factors in chest injury. J Trauma 1990;30:93.
7. Sondergaard HP, Hansson LO, Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta 2004;342:93.
8. Blanchard EB, Hickling EJ, Mitnick N, et al. The impact of severity of physical injury and perception of life threat in the development of post-traumatic stress disorder in motor vehicle accident victims. Behav Res Ther 1995;33:529.
9. Shalev AY, Freedman S, Peri T, et al. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry 1998;155:630.
10. Koren D, Arnon I, Klein E. Acute stress response and posttraumatic stress disorder in traffic accident victims: a one-year prospective, follow-up study. Am J Psychiatry 1999; 156:367.
11. Nightingale J, Williams RM. Attitudes to emotional expression and personality in predicting post-traumatic stress disorder. Br J Clin Psychol 2000;39(Pt 3):243.
12. Ursano RJ, Bell C, Eth S, et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry 2004;161:3.
13. Yehuda R. Post-traumatic stress disorder. N Engl J Med 2002; 346:108.
14. Von Kanel R, Bellingrath S, Kudielka BM. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiology 2009;46:473.
15. Andrews JA, Neises KD. Cells, biomarkers, and posttraumatic stress disorder: evidence for peripheral involvement in a central disease. J Neurochem 2012;120:26.
16. Spivak B, Shohat B, Mester R, et al. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry 1997;42:345.
17. Yehuda R. Clinical relevance of biologic findings in PTSD. Psychiatr Q 2002;73:123.
18. Sutherland AG, Alexander DA, Hutchison JD. Disturbance of pro-inflammatory cytokines in post-traumatic psychopathology. Cytokine 2003;24:219.
19. Miller RJ, Sutherland AG, Hutchison JD, et al. C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine 2001;13:253.
20. von Kanel R, Hepp U, Kraemer B, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007;41:744.
21. Spitzer C, Barnow S, Volzke H, et al. Association of posttraumatic stress disorder with low-grade elevation of Creactive protein: evidence from the general population. J Psychiatr Res 2010;44:15.
22. Ozer EJ, Best SR, Lipsey TL, et al. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull 2003;129:52.
23. McCanlies EC, Araia SK, Joseph PN, et al. C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 2011;55:74.
24. Javaherian K, Liu JF, Wang JC. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. Science 1978; 199:1345.
25. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248.
26. Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006;26:174.
27. Tang D, Kang R, Zeh HJ 3rd, et al. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010;1799:131.
28. Leelahavanichkul A, Huang Y, Hu X, et al. Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing high mobility group box protein-1. Kidney Int 2011;80:1198.
29. Oyama Y, Hashiguchi T, Taniguchi N, et al. High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Lab Invest 2010;90:853.
30. Abdulahad DA, Westra J, Bijzet J, et al. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther 2011;13:R71.
31. Elia L, Quintavalle M, Zhang J, et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009;16:1590.
32. Pan HF, Wu GC, Li WP, et al. High mobility group box 1: a potential therapeutic target for systemic lupus erythematosus. Mol Biol Rep 2010;37:1191.
33. Guo S, Xin Z, Geng L, Liu-na G. Reliability and validity of Chinese version of the impact of event scale-revised. Chin J Clin Psychol 2007;5:15.
34. Gao X, Luo X. PTSD-positive screening and factors influencing the mental state in victims evacuated/not evacuated from Wenchuan earthquake area within 1 month. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:504.
35. Richardson JD, Miller FB, Carrillo EH, et al. Complex thoracic injuries. Surg Clin North Am 1996;76:725.
36. LoCicero J 3rd, Mattox KL. Epidemiology of chest trauma. Surg Clin North Am 1989;69:15.
37. O'Donnell ML, Creamer M, Pattison P, et al. Psychiatric morbidity following injury. Am J Psychiatry 2004;161:507.
38. Warshaw MG, Fierman E, Pratt L, et al. Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD. Am J Psychiatry 1993;150:1512.
39. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427.
40. Malik ML, Connor KM, Sutherland SM, et al. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebocontrolled trial of fluoxetine. J Trauma Stress 1999;12:387.
41. Breslau N. Outcomes of posttraumatic stress disorder. J Clin Psychiatry 2001;62(Suppl 17):55.
42. Ehlers A, Mayou RA, Bryant B. Psychological predictors of chronic posttraumatic stress disorder after motor vehicle accidents. J Abnorm Psychol 1998;107:508.
43. Michaels AJ, Michaels CE, Moon CH, et al. Posttraumatic stress disorder after injury: impact on general health outcome and early risk assessment. J Trauma 1999; 47:460.
44. Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 2009;13:R174.
45. Abraham E. Unraveling the role of high mobility group box protein 1 in severe trauma. Crit Care 2009;13:1004.
46. Wang J, Yang H, Hu X, et al. Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res 2013;183:509.
47. Watanabe T, Kubota S, Nagaya M, et al. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 2005; 124:59.
48. Kojima M, Tanabe M, Shinoda M, et al. Role of high mobility group box chromosomal protein 1 in ischemiareperfusion injury in the rat small intestine. J Surg Res 2012;178:466.
49. Haas HS, Schauenstein K. Neuroimmunomodulation via limbic structuresdthe neuroanatomy of psychoimmunology. Prog Neurobiol 1997;51:195.
50. Zeng L, Zhang AQ, Gu W, et al. Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in southwest China. Surgery 2012;151:427.